JILLIAN PRICE: Open Payments
NPI 1679054613 · PINCKNEY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,108 in 33 payments from 9 companies in 2025. Trend: 2023 $622 · 2024 $1,101 · 2025 $1,108
Food & beverage: $997Education: $111
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 9 | $433 |
| E.R. Squibb & Sons, L.L.C. | 4 | $182 |
| Teva Pharmaceuticals USA, Inc. | 4 | $143 |
| Alkermes, Inc. | 5 | $114 |
| Otsuka America Pharmaceutical, Inc. | 3 | $72 |
| Supernus Pharmaceuticals, Inc. | 3 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| ABBVIE INC. | 2 | $39 |
| OWP Pharmaceuticals, Inc. | 1 | $21 |
Products named: Auvelity, COBENFY, LYBALVI, REXULTI, Qelbree, CAPLYTA, VRAYLAR, AUSTEDO XR.
Industry payments across MI — which companies pay providers there.
